Lu Wen Shi
Independent Non-Executive DirectorMr. Shi Luwen has been an Independent Non-Executive Director of Shandong Boan Biotechnology Co., Ltd. since March 25, 2022 and served as its Independent Director since March 23, 2021 until March 25, 2022. He is responsible for supervising and providing independent advice on the operations and management. Since December 2016, Mr. Shi has served as an independent non-executive director of Hospital Corporation of China Limited. Since June 2020, he has been serving as an independent non-executive director of Dragon Laboratory Instruments Limited. Mr. Shi has experience in the pharmaceutical industry. Since July 1987, he has been working at the School of Pharmaceutical Sciences of Peking University with his latest position as a professor in pharmaceutical administration and clinical pharmacy. Since 2002, he has been serving as a director of the International Research Center for Medical Administration of Peking University. From December 2015 to December 2021, he served as an independent director of China Meheco Group Co., Ltd. From May 2017 to July 2020, he served as a director of Zhejiang CONBA Pharmaceutical Co., Ltd. In November 2010, Mr. Shi was awarded the Xue Muqiao Price Research Award by the Price Association of China. In June 2012, he was awarded the Scientific Chinese Person (2011) by Scientific Chinese Magazine. In December 2018, he was awarded the Most Concerned Medical Reform Experts by Health News. Mr. Shi obtained a bachelor’s degree in chemistry from Peking University Health Science Center in the PRC in July 1987. He obtained an independent director qualification certificate from the SSE in January 2016. He also obtained a master’s degree in health professions education from the University of Illinois in the U.S. in July 1992.
Positions
- Company NameShandong Boan Biotechnology Co., Ltd.Stock Code06955PositionIndependent Non-Executive Director
